Patient Safety Initiatives Kelly Cronin Director, Patient Safety and Outcomes Research Office of Policy and Planning Office of the Commissioner FDA.

Slides:



Advertisements
Similar presentations
Mary Ellen Turner MD, MPH Vice-President
Advertisements

Overview of Risk management: A EU perspective Lincoln Tsang May 2008.
Unique Device Identification (UDI) System for Medical Devices Dr Larry Kelly Therapeutic Goods Administration.
Structured Product Labeling Overview
An Imperative for Performance Improvement
Unleashing Government Data and Information To Enable Transformation: Next Generation of CMS Compare Data Patrick Conway, M.D., MSc CMS Chief Medical Officer.
TIGER Standards & Interoperability Collaborative Informatics and Technology in Nursing.
California Department of Public Health Loriann De Martini, Pharm.D. Chief Pharmaceutical Consultant Center for Healthcare Quality Medication Error Reduction.
Medication Reconciliation Insert your hospital’s name here.
Center for Health Care Quality Licensing & Certification Program Evaluation 1 August 2014 rev.
Step 3 : Analyze nursing diagnoses relationships  Draw lines between nursing diagnoses to indicate relationships.  Prepared to verbally explain to your.
FDA Basics: Tissue Safety
[Hospital Name | Presenter name and title | Date of presentation]
ONC Policy and Program Update Health IT Standards Committee Meeting July 17, 2013 Jodi Daniel Director, Office of Policy and Planning, ONC 0.
MONDAY, 5:00 – 5:30PM Innovative Opportunities for Patient Safety Using Electronic Health Record (EHR) Data: Perspectives from the FDA FDA to CONNECT Mitra.
FDA’s MedWatch Program Outreach to Healthcare Professionals and the Public n Managing the Risks of Medical Product Use.
Center for Quality Improvement and Patient Safety Agency for Healthcare Research and Quality Presented to the ONC HIT Policy Committee – Safety Task Force.
William B Munier, MD, MBA, Director Center for Quality Improvement and Patient Safety Agency for Healthcare Research and Quality AHRQ Annual Conference.
ONC Policy and Program Update Health IT Policy Committee Meeting July 9, 2013 Jodi Daniel Director, Office of Policy and Planning, ONC 0.
April 8, 2005FDLI Annual Conference 1 Labeling Prescription Drugs for Physicians and Consumers (FDA Perspective) Paul J. Seligman, MD, MPH Director, Office.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
by Joint Commission International (JCI)
Epidemiology Tools and Methods Session 2, Part 1.
Interoperability to Support a Learning Health System HL7 Learning Health Systems Workgroup.
Pharmacy Services.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.
Pharmacovigilance Programme of India
Public Health Surveillance
“Crosswalking” Hospitals for a Healthy Environment (H2E) & the Joint Commission for the Accreditation of Healthcare Organizations (JCAHO) Catherine Zimmer,
Examples of ADE Surveillance Systems MedDRA ® Processing of Adverse Event Reports in ADE Surveillance Systems Amarilys Vega, M.D, M.P.H., Sonja Brajovic,
1 Medical Device Safety Susan Gardner, Ph.D. Director, Office of Surveillance and Biometrics Center for Devices and Radiological Health.
EHR Clinical data repository and pharmacovigilance Suzanne Markel-Fox 12 October 2007.
Chapter 6 – Data Handling and EPR. Electronic Health Record Systems: Government Initiatives and Public/Private Partnerships EHR is systematic collection.
PSO Education for [agency/organization]’s PSES Workgroup (Presenter) (Date) 1 **For internal use by Center for Patient Safety PSO Participants. May not.
PSO Overview for Executives (Presenter) (Date) Center for Patient Safety Toolkit for PSO Participation, Section 4.
The Status of Health IT in British Columbia Elaine McKnight.
Medication Use Process Part One, Lecture # 5 PHCL 498 Amar Hijazi, Majed Alameel, Mona AlMehaid.
Patient Safety in the VA William B Weeks, MD, MBA National Center for Patient Safety.
Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)
Copyright © 2006 Elsevier, Inc. All rights reserved Chapter 22 Quality Patient Care.
The Quality Colloquium at Harvard University August 27, 2003 Patient Safety Organizational Readiness Assessment Tool Louis H. Diamond, MDBeverly A. Collins,
Framing the Issue: FDA Perspective Product Tracing Sherri A. McGarry Center for Food Safety and Applied Nutrition Food and Drug Administration.
Evaluation of the Indiana ECCS Initiative. State Context Previous Early Childhood System Initiatives –Step Ahead –Building Bright Beginnings SPRANS Grant.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
Dispensary and Administration Site Information Presentation.
Barcode Technology in healthcare Nowadays, published reports illustrate high rates of medical error (adverse events) and the increasing costs of healthcare.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
July 15, Postmarketing Safety Evaluation of Approved Drugs and Risk Management Victor F. C. Raczkowski, MD, MS Director, Office of Drug Safety July.
Pharmacists’ Patient Care Process
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Minimum requirements for Pharmacovigilance in countries.
Postmarketing Pharmacovigilance Practice at FDA Lanh Green, Pharm.D., M.P.H. Office of Surveillance and Epidemiology June 21, 2006.
Risk Management of Modified- Release Opiate Analgesics: Palladone Sharon Hertz, M.D. Medical Team Leader, Analgesics Division of Anesthetic, Critical Care,
Informatics Technologies for Patient Safety Presented by Moira Jean Healey.
8 Medication Errors and Prevention.
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
An Integrated Risk Management & Safety Program: IRMSP
Update on the National Postmarket Surveillance System
Helen Lee, European Commission
Combination products The paradigm shift
Commission strategy to
Patient Involvement in the Development and Safe Use of
Robert Graham, MD Acting Deputy Director August 23, 2004
FDA Sentinel Initiative
Tobey Clark, Director*, Burlington USA
11 iii. Define management and supervision roles and responsibilities
8 Medication Errors and Prevention.
Presentation transcript:

Patient Safety Initiatives Kelly Cronin Director, Patient Safety and Outcomes Research Office of Policy and Planning Office of the Commissioner FDA

Overview Review strategic planning effort Review strategic planning effort Update on ongoing initiatives Update on ongoing initiatives Vision of future Vision of future Challenges Challenges

Strategic Planning: 5 Key Areas Strong FDA Strong FDA Risk management Risk management Focus on pre-approval activitiesFocus on pre-approval activities Better informed consumers Better informed consumers Patient and consumer safety Patient and consumer safety Focus on post-approval activitiesFocus on post-approval activities Counter-terrorism Counter-terrorism

Strategic Goal and Objectives for Patient Safety Improve patient and consumer safety by reducing risks of FDA- regulated products Improve patient and consumer safety by reducing risks of FDA- regulated products Enhance ability to quickly identify risks associated with FDA-regulated productsEnhance ability to quickly identify risks associated with FDA-regulated products Increase capacity to accurately analyze risks associated with FDA-regulated productsIncrease capacity to accurately analyze risks associated with FDA-regulated products Take appropriate actions to communicate risks and correct problems associated with FDA- regulated productsTake appropriate actions to communicate risks and correct problems associated with FDA- regulated products

4 Agency Wide Working Groups 1) Improving safety reporting systems across centers 2) Using external data sources to improve risk assessment 3) Improving risk communication to consumers and health care professionals 4) Developing new approaches to control and prevent risks

Adverse Event Reporting Systems Suspected Adverse Drug Reaction Rule proposed in March Suspected Adverse Drug Reaction Rule proposed in March Proposes new standards to improve the quality and usefulness of patient safety data submitted by industryProposes new standards to improve the quality and usefulness of patient safety data submitted by industry Would reduce industry’s reporting burden by using the same definitions and one common set of procedures worldwideWould reduce industry’s reporting burden by using the same definitions and one common set of procedures worldwide

Adverse Event Reporting Systems MedSun has 80 health care facilities enrolled to report device related adverse events MedSun has 80 health care facilities enrolled to report device related adverse events 100 sites to be added in the next year100 sites to be added in the next year Identifying potential partners that collect medical errors and adverse event data to access additional reports Identifying potential partners that collect medical errors and adverse event data to access additional reports

External Data Sources to Assess Risks Created an inventory of all in-house healthcare databases Created an inventory of all in-house healthcare databases IMS, Premier, Advanced PCS, etc.IMS, Premier, Advanced PCS, etc. Measure exposure and adverse eventsMeasure exposure and adverse events Identifying new databases that would supplement ability to analyze risks Identifying new databases that would supplement ability to analyze risks Planning to monitor higher risk products approved under PDUFA III Planning to monitor higher risk products approved under PDUFA III

Marconi Project A public-private collaboration to facilitate the development of standards for electronic communication of health care information A public-private collaboration to facilitate the development of standards for electronic communication of health care information FDA will receive reports on possible drug adverse events generated automatically from provider's electronic medical records FDA will receive reports on possible drug adverse events generated automatically from provider's electronic medical records Launch planned for June Launch planned for June

External Data Sources to Assess Risks Next steps include expanding the data collection with providers participating in the Marconi project Next steps include expanding the data collection with providers participating in the Marconi project Develop strategy for automatic data collection and analysis Develop strategy for automatic data collection and analysis For a real-time assessment of product risks from a representative sample of electronic medical recordsFor a real-time assessment of product risks from a representative sample of electronic medical records Must be compliant with HIPAAMust be compliant with HIPAA

Risk Communication Recently completed inventory of all types of risk communications across centers Recently completed inventory of all types of risk communications across centers Plan to evaluate the effectiveness of existing communication strategies Plan to evaluate the effectiveness of existing communication strategies Identifying new strategies to address weaknesses with current processes and dissemination vehicles Identifying new strategies to address weaknesses with current processes and dissemination vehicles Exploring new policy to communicate potential risks to health care professionals after signal detection Exploring new policy to communicate potential risks to health care professionals after signal detection

Risk Communication DailyMed initiative with NLM DailyMed initiative with NLM Provide health care information systems with up to date product labeling information in computer readable formatProvide health care information systems with up to date product labeling information in computer readable format Support multiple functions including prescribing decision applications use at the point of careSupport multiple functions including prescribing decision applications use at the point of care Other proposed initiatives include: Other proposed initiatives include: A dedicated web site for patient safety informationA dedicated web site for patient safety information Electronic distribution of patient safety newsElectronic distribution of patient safety news

Risk Prevention and Control Bar coding rule proposed in March Bar coding rule proposed in March Would require bar codes on prescription drugs, over-the-counter drugs packaged for hospital use, vaccines, blood and blood components.Would require bar codes on prescription drugs, over-the-counter drugs packaged for hospital use, vaccines, blood and blood components. Allow for unique identification of products through scanning bar codes that reflects the National Drug Code numberAllow for unique identification of products through scanning bar codes that reflects the National Drug Code number Expected to facilitate uptake of scanners in hospitals and prevent errors related to medication administration, i.e.,Expected to facilitate uptake of scanners in hospitals and prevent errors related to medication administration, i.e., Wrong drug Wrong drug Wrong dose Wrong dose Wrong time to administer a drug Wrong time to administer a drug

Risk Prevention and Control Identifying actions to correct safety problems and prevent adverse events Identifying actions to correct safety problems and prevent adverse events i.e., Risk-based recallsi.e., Risk-based recalls Release of concept papers on risk management programs and pharmacovigilance plans Release of concept papers on risk management programs and pharmacovigilance plans

Partnerships CDC CDC Data collection through existing surveys and surveillance systemsData collection through existing surveys and surveillance systems AHRQ AHRQ Establishing ways to facilitate data collection and share expertiseEstablishing ways to facilitate data collection and share expertise VA VA Working with PBM database and exploring several new projectsWorking with PBM database and exploring several new projects

Partnerships Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Communicate product related risks through JCAHO dissemination vehiclesCommunicate product related risks through JCAHO dissemination vehicles Share information related to root causes of medical errors, i.e., transfusion errorsShare information related to root causes of medical errors, i.e., transfusion errors

Vision for Patient Safety Spontaneous reporting systems are valuable but do not reveal the true safety profile for marketed medical products Spontaneous reporting systems are valuable but do not reveal the true safety profile for marketed medical products FDA needs to develop capability for automatic collection of safety data from health care providers information systems FDA needs to develop capability for automatic collection of safety data from health care providers information systems The flow of information across information systems will depend on partnerships with health care providers and interoperability standards The flow of information across information systems will depend on partnerships with health care providers and interoperability standards Healthcare databases will significantly improve the agency’s ability to identify and analyze product related risks Healthcare databases will significantly improve the agency’s ability to identify and analyze product related risks

Vision for Patient Safety More rapid detection of adverse events and medical errors and proactive management will significantly reduce risks associated with FDA-regulated products More rapid detection of adverse events and medical errors and proactive management will significantly reduce risks associated with FDA-regulated products Informed health care professionals and patients will be empowered to prevent adverse events and reduce morbidity and mortality, human suffering, and health care costs Informed health care professionals and patients will be empowered to prevent adverse events and reduce morbidity and mortality, human suffering, and health care costs

Challenges Budget constraints Budget constraints Reliance on partnerships Reliance on partnerships New initiatives are IT intensive New initiatives are IT intensive HHS directing IT consolidationHHS directing IT consolidation FDA has less control over IT resourcesFDA has less control over IT resources Limited resources make it difficult to recruit and keep talentLimited resources make it difficult to recruit and keep talent Have legacy IT systems and need to transition to new systems without interrupting our programs Have legacy IT systems and need to transition to new systems without interrupting our programs